相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Assessment of cardiovascular risk factors in patients with idiopathic inflammatory myopathies: a systematic review
Jucier Goncalves Junior et al.
CLINICAL RHEUMATOLOGY (2023)
An international audit of the management of dyslipidaemia and hypertension in patients with rheumatoid arthritis: results from 19 countries
Silvia Rollefstad et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2022)
Validation of methods to identify people with idiopathic inflammatory myopathies using hospital episode statistics
Jennifer R. Hannah et al.
RHEUMATOLOGY ADVANCES IN PRACTICE (2022)
Statin use in patients with non-HMGCR idiopathic inflammatory myopathies: A retrospective study
Sangmee Sharon Bae et al.
CLINICAL CARDIOLOGY (2020)
Lipid-lowering Therapies in Myositis
Marisa C. Mizus et al.
CURRENT RHEUMATOLOGY REPORTS (2020)
The Effect of Statin Use on Mortality in Systemic Autoimmune Rheumatic Diseases
April M. Jorge et al.
JOURNAL OF RHEUMATOLOGY (2018)
Validation of International Classification of Diseases Codes for the Epidemiologic Study of Dermatomyositis
Michael C. Kwa et al.
ARTHRITIS CARE & RESEARCH (2017)
Statin use and mortality in rheumatoid arthritis: a general population-based cohort study
Sara R. Schoenfeld et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Incidence and complications of interstitial lung disease in users of tocilizumab, rituximab, abatacept and anti-tumor necrosis factor a agents, a retrospective cohort study
Jeffrey R. Curtis et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Risk of coronary artery disease in patients with idiopathic inflammatory myopathies: A systematic review and meta-analysis of observational studies
Patompong Ungprasert et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2014)
Use of Lipid-lowering Agents in Rheumatoid Arthritis: A Population-based Cohort Study
Bharath Manu Akkara Veetil et al.
JOURNAL OF RHEUMATOLOGY (2013)
Lipid profiles in untreated patients with dermatomyositis
H. Wang et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
Statin-Induced Myotoxicity: Pharmacokinetic Differences among Statins and the Risk of Rhabdomyolysis, with Particular Reference to Pitavastatin
Alberico L. Catapano
Current Vascular Pharmacology (2012)
Mortality and its predominant causes in a large cohort of patients with biopsy-determined inflammatory myositis
V. Limaye et al.
INTERNAL MEDICINE JOURNAL (2012)
Impact of Statin Discontinuation on Mortality in Patients With Rheumatoid Arthritis: A Population-Based Study
Mary A. De Vera et al.
ARTHRITIS CARE & RESEARCH (2012)
Long-Term Efficacy of Pitavastatin Versus Simvastatin
Mats Eriksson et al.
ADVANCES IN THERAPY (2011)
Autoantibodies Against 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase in Patients With Statin-Associated Autoimmune Myopathy
Andrew L. Mammen et al.
ARTHRITIS AND RHEUMATISM (2011)
Patterns of cardiovascular risk in rheumatoid arthritis
D. H. Solomon et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients -: The PRIMO study
E Bruckert et al.
CARDIOVASCULAR DRUGS AND THERAPY (2005)
A comprehensive description of muscle symptoms associated with lipid-lowering drugs
S Franc et al.
CARDIOVASCULAR DRUGS AND THERAPY (2003)
Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis
MR Law et al.
BRITISH MEDICAL JOURNAL (2003)
分享论文
